# OnCo record clsp-5282 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/clsp-5282/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "clsp-5282" ;
  schema:name "CLSP-5282"@en ;
  schema:description "CLSP-5282 is an experimental T cell engager from Clasp Therapeutics, in phase 1 trials for KRAS G12V-mutant solid tumours in HLA-A*03:01-positive patients."@en ;
  schema:url <https://onco.cc/drugs/clsp-5282/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.clasptx.com/press-release-publications/clasp-therapeutics-unveils-first-in-class-kras-t-cell-engager-clsp-5282-at-aacr-2026>, <https://clinicaltrials.gov/study/NCT07650357>, <https://clinicaltrials.gov/search?intr=CLSP-5282> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "T cell engager" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:companies <https://onco.cc/companies/clasp-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07650357/> .